𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations of the transforming growth factor β type II receptor gene and microsatellite instability in gastric cancer

✍ Scribed by Masayuki Ohue; Naohiro Tomita; Takushi Monden; Yasuo Miyoshi; Tadashi Ohnishi; Hikaru Izawa; Yuuichi Kawabata; Masaya Sasaki; Mitsugu Sekimoto; Isamu Nishisho; Hitoshi Shiozaki; Morito Monden


Publisher
John Wiley and Sons
Year
1996
Tongue
French
Weight
517 KB
Volume
68
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Forty-three sporadic gastric cancers were analyzed with regard to whether mutations of simple repeated sequences in the transforming growth factor fi type II receptor ( T p -I / ) gene are associated with microsatellite instability (MSI) and gastric carcinogenesis. In 12 ofthe 43 cancers (28%), MSI was observed at least at I of the 2 microsatellite loci. Frameshift mutations of the TpR-/I gene, all of which were I base deletion of I0 adenine repeats, were detected in 3 of 6 cancers, with MSI at 2 loci. However, mutations were not detected in 6 cancers, with MSI only at I locus and 31 cancers without MSI. Moreover, microanalysis in these cases revealed that the mutant-type alleles of TpR-I/ were invariably common in different areas within the tumor. in contrast to the markedly variable alleles of microsatellite loci. Our results suggest that frameshift mutation of the T/3R-/I gene may be a critical event associated with MSI and may contribute to carcinogenesis of the stomach. One of the possible mechanisms of escape from growth control by TGFfi during gastric carcinogenesis could involve frameshift mutations of the TPR-II gene caused by DNA replication errors.


📜 SIMILAR VOLUMES


Gene mutation of transforming growth fac
✍ Keiko Furuta; Sachiko Misao; Kiyoshi Takahashi; Tsuneaki Tagaya; Yoshitaka Fukuz 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 146 KB 👁 1 views

Alteration of transforming growth factor beta1 (TGF-beta1) type II receptor (RII) appears to cause unresponsiveness to TGF-beta1 in tumorigenic cells. Defect in the mononucleotide repeat sequence, i.e., poly A region of TGF-beta1RII gene has been reported to be related to replication error-positive

Novel inactivating mutations of transfor
✍ Taiping Chen; Wu Yan; Rebecca G. Wells; David L. Rimm; Jennifer McNiff; David Le 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 263 KB

Carcinoma cell lines are frequently refractory to transforming growth factor-beta (TGF beta)-mediated cell cycle arrest. Whether and how TGF beta signaling is disrupted in the majority of human tumors, however, remains unclear. To investigate whether TGF beta signaling might be disrupted by inactiva

Mutation of the transforming growth fact
✍ Iacopetta, Barry J.; Welch, John; Soong, Richie; House, Anthony K.; Zhou, Xiao-P 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

The presence of inactivating mutations in the transforming growth factor-beta (TGF-beta) type II receptor (RII) gene in the colon cancer suggests that it may behave like a tumour suppressor gene. RII is mutated in the majority of colon tumours exhibiting widespread microsatellite instability, a char

Enhanced tumorigenesis and reduced trans
✍ Yang Kang; Jennifer M. Mariano; Jerry Angdisen; Terry W. Moody; Bhalchandra A. D 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 1 views

To elucidate the role of transforming growth factor-beta1 (TGF-beta1) and the TGF-beta type II receptor (TGF-beta RII) as tumor-suppressor genes in lung carcinogenesis, we mated C57BL/6 mice heterozygous (HT) for deletion of the TGF-beta1 gene with A/J mice to produce AJBL6 TGF-beta1 HT progeny and

Lack of transforming growth factor-β typ
✍ Kuniko Horie; Hidetoshi Yamashita; Akira Mogi; Seiichi Takenoshita; Kohei Miyazo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 1 views

Retinoblastoma cells are resistant to transforming growth factor-b (TGF-b) activity due to the absence of TGF-b binding. To further elucidate the mechanism of TGF-b resistance, we studied the expression of the TGF-b receptors and SMADs by using the Y79 and WERI-Rb-1 retinoblastoma cell lines. Bindin